ZIOPHARM Oncology, Inc.
(NASDAQ : ZIOP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 5.52%58.610.0%$1744.69m
GILDGilead Sciences, Inc. -0.27%75.121.0%$1314.92m
REGNRegeneron Pharmaceuticals, Inc. 0.67%582.102.5%$967.82m
AMGNAmgen, Inc. -0.22%223.631.3%$644.89m
NVAXNovavax, Inc. 0.36%45.00102.0%$581.79m
VRTXVertex Pharmaceuticals, Inc. 0.26%278.111.9%$546.14m
BIIBBiogen, Inc. -0.01%300.471.6%$410.35m
ILMNIllumina, Inc. -1.72%366.613.5%$382.50m
SRNESorrento Therapeutics, Inc. 0.41%4.971.8%$298.90m
ALXNAlexion Pharmaceuticals, Inc. 1.57%116.222.0%$269.23m
SGENSeattle Genetics, Inc. -0.08%151.436.1%$254.30m
AAgilent Technologies, Inc. 0.58%87.191.6%$200.66m
BMRNBioMarin Pharmaceutical, Inc. -1.26%104.274.3%$177.51m
CODXCo-Diagnostics, Inc. -0.60%17.370.0%$169.88m
INCYIncyte Corp. -0.46%100.092.5%$156.77m

Company Profile

ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of immuno-oncology platforms that leverage cell- and gene-based therapies to treat patients with cancer. Its pipeline includes Sleeping Beauty TCR-T Targeting neoantigens; Ad-RTS-hlL-12 + veledimex; and Sleeping Beauty CAR-T. The company was founded on September 9, 2003 and is headquartered in Boston, MA.